113 related articles for article (PubMed ID: 8658649)
1. Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients.
Shinozuka N; Koyama I; Omoto R; Burdick J
Transplant Proc; 1996 Jun; 28(3):1259. PubMed ID: 8658649
[No Abstract] [Full Text] [Related]
2. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
3. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
4. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
5. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
7. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
[No Abstract] [Full Text] [Related]
8. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
9. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: a preliminary report.
Zhong R; Tucker J; Grant D; Wall W; Garcia B; Asfar S; Zhang Z; Sharpe M; Gelb A; Stiller C
Transplant Proc; 1996 Apr; 28(2):762. PubMed ID: 8623388
[No Abstract] [Full Text] [Related]
11. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus in solid organ transplantation: an update.
Shapiro R
Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
[No Abstract] [Full Text] [Related]
13. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.
Neumann UP; Lang M; Moldenhauer A; Langrehr JM; Glanemann M; Kahl A; Frei U; Bechstein WO; Neuhaus P
Transplantation; 2001 Apr; 71(8):1163-8. PubMed ID: 11374419
[TBL] [Abstract][Full Text] [Related]
14. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
[TBL] [Abstract][Full Text] [Related]
15. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients.
Takahara S; Kokado Y; Kameoka H; Takano Y; Moutabarrik A; Jiang H; Ishibashi M; Okuyama A; Nishi Y; Chiba N
Transplant Proc; 1994 Oct; 26(5):2802-6. PubMed ID: 7524219
[No Abstract] [Full Text] [Related]
17. Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.
MacDonald AS
Transplant Proc; 2003 May; 35(3 Suppl):201S-208S. PubMed ID: 12742497
[TBL] [Abstract][Full Text] [Related]
18. Four-year follow-up of the European Tacrolimus Multicenter Renal Study.
Mayer AD
Transplant Proc; 1999 Nov; 31(7A):27S-28S. PubMed ID: 10576038
[No Abstract] [Full Text] [Related]
19. Immunocompetence assay for net effect of combined immunosuppression.
Nagashima N; Shalabi A; Watanabe T; Ogawa N; Koyama I; Kyo S; Burdick JF
Transplant Proc; 2001 May; 33(3):2350-1. PubMed ID: 11377556
[No Abstract] [Full Text] [Related]
20. Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study.
Weimer R; Streller S; Staak A; Heilke M; Li D; Dietrich H; Daniel V; Feustel A; Rainer L; Zinn S; Friemann S; Ernst W; Grimm H; Padberg W; Zimmermann T; Opelz G
Transplant Proc; 2002 Sep; 34(6):2377-8. PubMed ID: 12270445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
